Pulsetto, a company that helps people relieve stress through its science-based vagus nerve stimulation (VNS) device, introduced an innovative technological solution to battle this issue. Their device helps people manage stress, sleep, avoid burnout, and improve emotional wellbeing.

The device is simply placed it on a person’s neck to stimulate vagus nerve, which immediately causes deep relaxation by delivering calming vibrations.

Pulsetto saw remarkable growth in 2024, with gross revenue hitting $10 million. This is a 3.5x increase from the previous year and a 56x growth since the company’s launch in 2021. Over the year, 39,367 orders for devices were processed through a network of more than 70 active distributors.

“We built this company with a €500,000 investment from Kilo Health and our own resources,” said Vitalijus Majorovas, healthtech hacker and Co-Founder of Pulsetto. “This was enough for us to develop Pulsetto VNS technology and be profitable from day one.”

Pulsetto’s 100,000+ users completed over 1.3 million stress-relief sessions in 2024, which shows that the trust in the company’s VNS technology for managing mental health has been growing steadily. Most users are from the US, Canada, Australia, the UK, and Germany.

Pulsetto gained international attention in 2024 through its feature in the Netflix documentary Don’t Die: The Man Who Wants to Live Forever. The film, featuring health optimisation pioneer Bryan Johnson, positioned Pulsetto as an important tool in the longevity movement, emphasising its role in improving quality of life and extending health spans.

“Preventive wellness practices and longevity are rapidly becoming central to health innovation,” said Povilas Sabaliauskas, stress management expert and Pulsetto Co-Founder. “We have to be proactive, and use available solutions that can get faster results to recover from stress instead of waiting for a nervous breakdown. VNS devices have already proved how advanced drug-free solutions can address mental health challenges. I believe that by helping users manage stress, improve sleep, and enhance recovery, we’re contributing to a broader shift toward proactive, sustainable health practices.”

Since 2024, the device has had API integrations that allow users to monitor heart rate and heart rate variability (HRV) in real time. It offers a more personalised approach to stress management.

The company is now advancing with clinical trials and expanding its applications in wellness and beyond. It is planning a series of medical trials that are gathering concrete data on vagus nerve stimulation’s effectiveness in dealing with issues such as sleep disorders, chronic stress, and anxiety. 

“We have a clear mission for 2025: to expand the boundaries of what VNS technology can achieve,” said Majorovas. “We’re exploring applications in areas like blood pressure regulation, inflammation, and even PTSD treatment. We hope that big data becomes more integrated into traditionally non-tech fields like medicine, and there will be more targeted and personalized approaches on how to improve wellness, speed up recovery, and stop mental health issues before they escalate.”

For more startup news, check out the other articles on the website, and subscribe to the magazine for free. Listen to The Cereal Entrepreneur podcast for more interviews with entrepreneurs and big-hitters in the startup ecosystem.